检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王栋[1] 张曙光[2] 江小伟[1] 蔡廷江[1]
机构地区:[1]解放军第97医院神经外科 [2]江苏大学附属昆山医院神经外科
出 处:《临床神经外科杂志》2012年第4期207-209,共3页Journal of Clinical Neurosurgery
基 金:昆山社会发展项目基金(KS1006和KS1009)
摘 要:目的探讨丙戊酸钠治疗脑外伤术后癫疒间复发后,添加奥卡西平或拉莫三嗪联合治疗外伤性癫疒间效果。方法以治疗前3个月癫疒间发作频度为对照,对治疗12个月后的疗效、不良反应及安全性进行自身对比观察。结果应用奥卡西平或拉莫三嗪联合丙戊酸钠治疗12个月后,患者发作频率均较用药前明显减少;发作频率减少≥50%的患者分别为89.2%和89.7%,用药前后差异无统计学意义(P<0.05);奥卡西平或拉莫三嗪联合丙戊酸钠两组间差无明显统计学意义(P>0.05)。奥卡西平联合丙戊酸钠不良反应的发生率为19.3%,拉莫三嗪联合丙戊酸钠不良反应的发生率为9.1%,差异显著(P<0.05)。结论奥卡西平或拉莫三嗪联合丙戊酸钠治疗外伤性癫疒间复发疗效确切,副作用拉莫三嗪组明显低于奥卡西平组。Objective To compare the effect of Oxcarbazepine or lamotrigine joint treatment on traumatic epilepsy relapse after Valproic acid given alone. Methods 3 months before the combine treatment of seizure frequency was as the control, and after 12 months of joint treatment, the efficacy, adverse effects and safety was compared respectively. Results After application of Oxcarbazepine or I_amotrigine combined Valproic acid treatment for 12 months, the patient' s seizure frequency decreased significantly compared with before. Seizure frequency reduction of I〉 50% of patients reached 89.2% and 89.7% separately, and statistically significant difference was observed before and after joint treatment (P 〈 0. 05 ). There was also significant difference between two groups of Oxcarbazepine or Lamotrigine combined Valproic acid treatment (P 〈 0.05 ). The adverse events of Oxcarbazepine combined Valproic acid treatment was 19.3%, while Lamotrigine combined Valproic acid treatment adverse events was 9.1%, difference was significant. Conclusion Oxcarbazepine or Lamotrigine combined Valproic acid treatment of traumatic epilepsy recurrence is effective, and the side effects of combination of Lamotrigine and Valproic acid was lighter.
分 类 号:R742.1[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.30